ArticleHaematologica2020
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols.
Abstract read
In one paragraph
Article in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.The Lancet. Haematology · 2021Trial
- The partner gene modulates response to asciminib in ABL1-rearranged Acute Lymphoblastic Leukemia.Neoplasia (New York, N.Y.) · 2026Article
- DifferentialHemaSphere · 2026Article
- From the bench of molecular understanding to the bedside of optimal therapy forEJC paediatric oncology · 2025Article
- Review
- Targeting senescent stemlike subpopulations in Philadelphia chromosome-like acute lymphoblastic leukemia.Blood · 2025Article
- Review
- The Role of Candidate Polymorphisms in Drug Transporter Genes on High-Dose Methotrexate in the Consolidation Phase of the AIEOP-BFM ALL 2009 Protocol.Clinical and translational science · 2025Article
- Review
- Detection and Management of Invasive Mold Disease in Pediatric Hematological Cancer Patients.Infection and drug resistance · 2025Review
- Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report.BMC pediatrics · 2024Article
- The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia.BMC medical genomics · 2024Article
- Pilot study shows suppression of mineralocorticoid precursors under high-dose glucocorticoid therapy in pediatric acute lymphoblastic leukemia.Endocrine connections · 2023Article
- Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia.HemaSphere · 2023Article
- Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.Leukemia · 2023Article
- Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia.Annals of hematology · 2023Article
- Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia.Frontiers in oncology · 2023Article
- Clinical screening for Ph-like ALL and the developing role of TKIs.Hematology. American Society of Hematology. Education Program · 2022Article
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.British journal of cancer · 2022Article
- Review
Corrections and comments
- Commented on by
Authors and funding
35 authors.
Gunnar CarioPediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany gunnar.cario@uksh.de.
Veronica LeoniClinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.
Valentino ConterClinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.
Andishe AttarbaschiSt. Anna Kinderspital and Children's Cancer Research Institute, Vienna, Austria.
Marketa ZaliovaCLIP, Department of Pediatric Hematology and Oncology, 2Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Lucie SramkovaCLIP, Department of Pediatric Hematology and Oncology, 2Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Gianni CazzanigaClinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.
Grazia FazioClinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.
Rosemary SuttonMolecular Diagnostics, Children's Cancer Institute, University of NSW, Sydney, NSW, Australia.
Sarah ElitzurPediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Israel.
Shai IzraeliPediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Israel.
Melchior LautenPediatrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Franco LocatelliDepartment of Pediatric Hematology and Oncology, Scientific Institute for Research and Healthcare (IRCCS) Childrens' Hospital Bambino Gesù, Sapienza, University of Rome, Rome, Italy.
Giuseppe BassoIIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy.
Barbara BuldiniIIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy.
Anke K BergmannDepartment of Human Genetics, Medical School Hannover, Hannover, Germany.
Jana LentesDepartment of Human Genetics, Medical School Hannover, Hannover, Germany.
Doris SteinemannDepartment of Human Genetics, Medical School Hannover, Hannover, Germany.
Gudrun GöhringDepartment of Human Genetics, Medical School Hannover, Hannover, Germany.
Brigitte SchlegelbergerDepartment of Human Genetics, Medical School Hannover, Hannover, Germany.
Oskar A HaasSt. Anna Kinderspital and Children's Cancer Research Institute, Vienna, Austria.
Denis SchewePediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Swantje BuchmannPediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Anja MoerickePediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Deborah WhiteCancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
Tamas ReveszWomen's and Children's Hospital, SA Pathology, University of Adelaide, Adelaide, Australia.
Martin StanullaDepartment of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.
Georg MannSt. Anna Kinderspital and Children's Cancer Research Institute, Vienna, Austria.
Nicole BodmerUniversity Children's Hospital Zurich, Zurich, Switzerland.
Nira Arad-CohenPediatric Hematology-Oncology Department, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Jan ZunaCLIP, Department of Pediatric Hematology and Oncology, 2Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Maria Grazia ValsecchiClinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.
Martin ZimmermannDepartment of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.
Martin SchrappePediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Andrea BiondiClinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ABL-class fusions other than
Indexed as
Precursor B-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsB-LymphocytesChildHumansNeoplasm, ResidualPrognosisRecurrence
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.